Ixazomib (MLN-2238)
Product Sizes
5 mg
£215.00
F1110-5MG
About this Product
- SKU:
- F1110
- Buffer:
- Powder; no buffer
- Extra Details:
- Ixazomib (MLN2238) (commercial name: Ninlaro®) is the first and only FDA-approved oral proteasome inhibitor for the treatment of multiple myeloma. It reversibly inhibits the chymotrypsin-like activity of proteasomes with IC50 of 3.4 nM in cell-free assays, also inhibits the caspase-like and trypsin-like activities of proteasome with IC50 of 31 and 3500 nM, respectively.
- Molecular Weight:
- 361.03 g/mol
- Shipping Conditions:
- Ambient
- Source:
- chemical synthesis
- Storage Conditions:
- -20 0C
- Supplier:
- UBP Bio
- Type:
- Proteins, Peptides, Small Molecules & Other Biomolecules
